ArticleJournal for immunotherapy of cancer2020

Combination therapy with T cell engager and PD-L1 blockade enhances the antitumor potency of T cells as predicted by a QSP model.

Huilin Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.